Boc-3-Fluoro-L-Phenylalanine

Boc-3-Fluoro-L-Phenylalanine is an Fmoc-free, Boc-protected amino acid building block derived from L-phenylalanine, bearing a fluorine substituent on the meta position of the aromatic side chain. The Boc group provides a protected N-terminus for controlled incorporation into peptide sequences, while the aryl fluorine enables downstream chemical handling and structure-property tuning in medicinal chemistry and peptide-based research. This reagent is commonly selected when an aryl-fluoro stereodefined residue is needed for SAR studies, conformational/chemical stability investigations, or as a defined intermediate for fluorinated peptide and peptidomimetic synthesis.

1. Peptide Building Block Use

Boc-3-Fluoro-L-Phenylalanine is used as a fluorinated residue for custom peptide synthesis and peptide library construction where an aryl-fluoro analog of phenylalanine is required at a defined position. Researchers in peptide chemistry and chemical biology incorporate this protected amino acid during protected-amino-acid assembly workflows to generate peptides with a controlled meta-fluoro substitution pattern, supporting structure-activity relationship (SAR) exploration and analog series development. The Boc-protected format helps streamline handling and coupling during stepwise assembly, while the meta-fluoro aromatic side chain provides a chemically distinct substitution that can influence physicochemical properties and enable comparative studies against non-fluorinated phenylalanine analogs.

2. Medicinal Chemistry SAR Analogues

Boc-3-Fluoro-L-Phenylalanine is frequently used in medicinal chemistry to prepare fluorinated peptidomimetics and peptide-like fragments for SAR campaigns that require systematic variation of aromatic substitution. Medicinal chemistry groups and contract research organizations use this building block to introduce a meta-fluoro phenylalanine element into larger scaffolds, enabling direct comparison of analogs differing by fluorination pattern while keeping the backbone and side-chain framework otherwise consistent. The presence of the aryl fluorine makes this residue a practical choice for tuning lipophilicity, electronic effects, and metabolic stability hypotheses in fluorinated analog design, and it also supports downstream derivatization strategies where a defined fluorinated aromatic motif is advantageous.

3. Pharmaceutical Intermediate Synthesis

Boc-3-Fluoro-L-Phenylalanine serves as a protected intermediate for downstream synthesis of fluorinated amino acid derivatives and advanced building blocks used in pharmaceutical intermediate development. Process chemistry and synthetic chemistry teams employ this reagent when a Boc-protected, stereodefined fluorinated phenylalanine unit is needed as an input for further functionalization, coupling, or conversion into other protected or activated forms. The meta-fluoro aromatic substitution is a key structural handle for creating defined fluorinated intermediates that can be carried through multi-step routes to generate final fluorinated targets, including fluorinated peptide fragments and peptidomimetic precursors.

4. Fluorinated Peptidomimetic Fragments

Boc-3-Fluoro-L-Phenylalanine is applied to the synthesis of fluorinated peptidomimetic fragments and constrained analogs where the meta-fluoro phenyl ring is incorporated as a specific structural element. Chemical biology and medicinal chemistry teams use the Boc-protected amino acid to build defined fragments that can be assembled into larger constructs for receptor-binding studies, protein interaction mapping, or mechanistic probe development, while maintaining a consistent fluorinated aromatic motif across analog sets. The protected N-terminus supports controlled fragment assembly, and the meta-fluoro side chain provides a distinct chemical identity that helps differentiate analogs in structure-property and structure-function workflows.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes